Nektar Therapeutics
(LTS:0UNL)
$
66
+4.33 (+7.02%)
Market Cap: 2.21 Bil
Enterprise Value: 1.72 Bil
PE Ratio: 0
PB Ratio: 3.34
GF Score: 49/100 Nektar Therapeutics (LTS:0UNL) Transcripts
- 1